Literature DB >> 10807558

Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.

F Y Bois1.   

Abstract

Two physiologically based pharmacokinetic models for trichloroethylene (TCE) in mice and humans were calibrated with new toxicokinetic data sets. Calibration is an important step in model development, essential to a legitimate use of models for research or regulatory purposes. A Bayesian statistical framework was used to combine prior information about the model parameters with the data likelihood to yield posterior parameter distributions. For mice, these distributions represent uncertainty. For humans, the use of a population statistical model yielded estimates of both variability and uncertainty in human toxicokinetics of TCE. After adjustment of the models by Markov chain Monte Carlo sampling, the mouse model agreed with a large part of the data. Yet, some data on secondary metabolites were not fit well. The posterior parameter distributions obtained for mice were quite narrow (coefficient of variation [CV] of about 10 or 20%), but these CVs might be underestimated because of the incomplete fit of the model. The data fit, for humans, was better than for mice. Yet, some improvement of the model is needed to correctly describe trichloroethanol concentrations over long time periods. Posterior uncertainties about the population means corresponded to 10-20% CV. In terms of human population variability, volumes and flows varied across subject by approximately 20% CV. The variability was somewhat higher for partition coefficients (between 30 and 40%) and much higher for the metabolic parameters (standard deviations representing about a factor of 2). Finally, the analysis points to differences between human males and females in the toxicokinetics of TCE. The significance of these differences in terms of risk remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807558      PMCID: PMC1637766          DOI: 10.1289/ehp.00108s2275

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

1.  Development of new technique for risk assessment using physiologically based toxicokinetic models.

Authors:  G Johanson; F Jonsson; F Bois
Journal:  Am J Ind Med       Date:  1999-09       Impact factor: 2.214

2.  Population toxicokinetics of tetrachloroethylene.

Authors:  F Y Bois; A Gelman; J Jiang; D R Maszle; L Zeise; G Alexeef
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

3.  A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.

Authors:  R Abbas; J W Fisher
Journal:  Toxicol Appl Pharmacol       Date:  1997-11       Impact factor: 4.219

4.  Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.

Authors:  R R Abbas; C S Seckel; J K Kidney; J W Fisher
Journal:  Drug Metab Dispos       Date:  1996-12       Impact factor: 3.922

5.  Population toxicokinetics of benzene.

Authors:  F Y Bois; E T Jackson; K Pekari; M T Smith
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

6.  Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice.

Authors:  M V Templin; J C Parker; R J Bull
Journal:  Toxicol Appl Pharmacol       Date:  1993-11       Impact factor: 4.219

7.  Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites.

Authors:  R D Stenner; J L Merdink; J W Fisher; R J Bull
Journal:  Risk Anal       Date:  1998-06       Impact factor: 4.000

Review 8.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

9.  Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics.

Authors:  F Y Bois
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

  9 in total
  16 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities.

Authors:  Panos G Georgopoulos; Alan F Sasso; Sastry S Isukapalli; Paul J Lioy; Daniel A Vallero; Miles Okino; Larry Reiter
Journal:  J Expo Sci Environ Epidemiol       Date:  2008-03-26       Impact factor: 5.563

3.  PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-21       Impact factor: 4.219

4.  Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis.

Authors:  Frederique Fenneteau; Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

5.  A Bayesian population PBPK model for multiroute chloroform exposure.

Authors:  Yuching Yang; Xu Xu; Panos G Georgopoulos
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-05-27       Impact factor: 5.563

6.  Quantitative Characterization of Population-Wide Tissue- and Metabolite-Specific Variability in Perchloroethylene Toxicokinetics in Male Mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Sci       Date:  2021-08-03       Impact factor: 4.849

Review 7.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 8.  Issues in the pharmacokinetics of trichloroethylene and its metabolites.

Authors:  Weihsueh A Chiu; Miles S Okino; John C Lipscomb; Marina V Evans
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

Review 9.  Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.

Authors:  L R Rhomberg
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 10.  Human health effects of trichloroethylene: key findings and scientific issues.

Authors:  Weihsueh A Chiu; Jennifer Jinot; Cheryl Siegel Scott; Susan L Makris; Glinda S Cooper; Rebecca C Dzubow; Ambuja S Bale; Marina V Evans; Kathryn Z Guyton; Nagalakshmi Keshava; John C Lipscomb; Stanley Barone; John F Fox; Maureen R Gwinn; John Schaum; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2012-12-18       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.